These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 6040790)

  • 1. The physiology of fibrinolysis. II. Antiplasmin.
    Thornes RD; O'Donnell JM; O'Brien DJ
    Ir J Med Sci; 1967 Feb; 6(494):73-81. PubMed ID: 6040790
    [No Abstract]   [Full Text] [Related]  

  • 2. Tranexamic acid: more than inhibition of fibrinolysis?
    Couturier R; Grassin-Delyle S
    Anesth Analg; 2014 Aug; 119(2):498-499. PubMed ID: 25046793
    [No Abstract]   [Full Text] [Related]  

  • 3. [Natural inhibitors of fibrinolysis and their physiological importance].
    Pastorova VE
    Usp Fiziol Nauk; 1974; 5(4):80-95. PubMed ID: 4279526
    [No Abstract]   [Full Text] [Related]  

  • 4. [Fibrinolysis in internal medicine].
    Breda R; Bizzi B
    Minerva Med; 1972 Dec; 63(88):4803-7. PubMed ID: 4641450
    [No Abstract]   [Full Text] [Related]  

  • 5. A possible role of thrombin-activatable fibrinolysis inhibitor in disturbances of fibrinolytic system in renal transplant recipients.
    Hryszko T; Malyszko J; Malyszko JS; Brzosko S; Pawlak K; Mysliwiec M
    Nephrol Dial Transplant; 2001 Aug; 16(8):1692-6. PubMed ID: 11477176
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In response.
    Yee BE; Eaton MP
    Anesth Analg; 2014 Aug; 119(2):499. PubMed ID: 25046794
    [No Abstract]   [Full Text] [Related]  

  • 7. Fibrinolytic activation with intrauterine fetal death.
    Haznedaroglu S; Ozcan T; Karaaslan Y; Haznedaroglu I; Gokmen O; Kirazh S
    N Z Med J; 1998 Apr; 111(1063):130. PubMed ID: 9594975
    [No Abstract]   [Full Text] [Related]  

  • 8. Natural inhibitors of fibrinolysis.
    Collen D
    J Clin Pathol Suppl (R Coll Pathol); 1980; 14():24-30. PubMed ID: 6448870
    [No Abstract]   [Full Text] [Related]  

  • 9. Haemodilution-induced profibrinolytic state is mitigated by fresh-frozen plasma: implications for early haemostatic intervention in massive haemorrhage.
    Bolliger D; Szlam F; Levy JH; Molinaro RJ; Tanaka KA
    Br J Anaesth; 2010 Mar; 104(3):318-25. PubMed ID: 20133450
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New insights about the use of tranexamic acid in children undergoing cardiac surgery: from pharmacokinetics to pharmacodynamics.
    Faraoni D; Goobie SM
    Anesth Analg; 2013 Oct; 117(4):760-762. PubMed ID: 24057950
    [No Abstract]   [Full Text] [Related]  

  • 11. Alpha2-antiplasmin and its deficiency: fibrinolysis out of balance.
    Carpenter SL; Mathew P
    Haemophilia; 2008 Nov; 14(6):1250-4. PubMed ID: 19141165
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resting levels of fibrinolysis in blood in inactive and exercising men.
    Moxley TR; Brakman P; Astrup T
    J Appl Physiol; 1970 May; 28(5):549-52. PubMed ID: 5442247
    [No Abstract]   [Full Text] [Related]  

  • 13. Systematic elucidation of effects of tranexamic acid on fibrinolysis and bleeding during and after cardiopulmonary bypass surgery.
    Kojima T; Gando S; Morimoto Y; Mashio H; Goda Y; Kawahigashi H; Kemmotsu O
    Thromb Res; 2001 Dec; 104(5):301-7. PubMed ID: 11738071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fibrinolysis/proteolysis balance in stable angina pectoris in relation to angiographic findings.
    Páramo JA; Orbe J; Fernández J
    Thromb Haemost; 2001 Aug; 86(2):636-9. PubMed ID: 11522015
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional activities and concentrations of plasmin inhibitors in normal subjects and D.I.C. patients.
    Velasco F; Torres A; Andres P; Duran MI
    Thromb Haemost; 1982 Jun; 47(3):275-7. PubMed ID: 6180498
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiplasmin activity of electrophoretically separated human serum fractions.
    Mann RD; Cotton S; Jackson D
    J Clin Pathol; 1966 Mar; 19(2):185-9. PubMed ID: 4160096
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Change in antiplasmin activity in patients with neoplasms of the urinary bladder].
    Zavadich IB; Kotovshchikova MA; Fedorova ZD
    Urol Nefrol (Mosk); 1970; 35(1):45-7. PubMed ID: 5524840
    [No Abstract]   [Full Text] [Related]  

  • 18. Pattern of the activator inhibitor in carcinoma and renal diseases.
    Hedner U; Nilsson IM
    Scand J Haematol; 1973; 11(5):398-404. PubMed ID: 4798342
    [No Abstract]   [Full Text] [Related]  

  • 19. The effect of pre-eclampsia on coagulation and fibrinolytic activation in the neonate.
    Higgins JR; Bonnar J; Norris LA; Darling MR; Walshe JJ
    Thromb Res; 2000 Sep; 99(6):567-70. PubMed ID: 10974342
    [No Abstract]   [Full Text] [Related]  

  • 20. [ON THE DEFENSIVE REFLEX ANTIPLASMIN SYSTEM IN THE BODY].
    KUDRIASHOV BA; KALISHEVSKAIA TM
    Biull Eksp Biol Med; 1963 Sep; 56():29-33. PubMed ID: 14124776
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.